• Research Topics

Found 4650 Results
Page 5 of 47

orcid publication

Novel agents for the treatment of human cytomegalovirus infection


orcid publication

Nonnucleoside human cytomegalovirus inhibitors: Synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives


orcid publication

N-benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors


orcid publication

Lipase-catalysed synthesis of new acetylcholinesterase inhibitors: N-benzylpiperidine aminoacid derivatives


orcid publication

Hindered inversion/rotation in diheteroaryl alkyl amines with a N-(1-pyrazolyl) group: Dynamic NMR and molecular modelling studies


orcid publication

Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: First phosphodiesterase 7 inhibitors


orcid publication

Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: Synthesis and comparative molecular field analysis


orcid publication

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders


orcid publication

Recent strategies in the development of new human cytomegalovirus inhibitors


orcid publication

Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimer's Disease


orcid publication

O-Pyrazolylpropynyl-Hydroxylamines as Versatile Intermediates in the Synthesis of Compounds of Pharmacological Interest


orcid publication

CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors


orcid publication

Anti-HIV-1 Activity of Benzothiadiazine Dioxide


orcid publication

Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimer's Disease


orcid publication

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?


orcid publication

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation


orcid publication

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3 beta) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease


orcid publication

An experimental NMR and semi-empirical theoretical study of the conformation of styrylchromones and styryl alkyl or aryl ketones (benzylidene ketones)


orcid publication

APPLICATION OF ULTRASONIC NEBULIZATION FOR THE DETERMINATION OF RARE-EARTH ELEMENTS IN PHOSPHATES AND RELATED SEDIMENTARY-ROCKS USING INDUCTIVELY-COUPLED PLASMA-ATOMIC EMISSION-SPECTROMETRY WITH COMMENTS ON DISSOLUTION PROCEDURES


orcid publication

Thienyl and phenyl alpha-halomethyl ketones: New inhibitors of glycogen synthase kinase (GSK-3 beta) from a library of compound searching


orcid publication

Synthesis and muscarinic activities of O-[benzyl- or benzoylpyrazolyl)propynyl]-oximes of N-methylpiperidinone, 3-tropinone, and 3-quinuclidinone


orcid publication

Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. Study of structural requirements for biological activity


orcid publication

AMPA glutamate receptors and neuropathic pain.


orcid publication

Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice


orcid publication

GSK-3 inhibitors: Discoveries and developments


orcid publication

CODES/Neural network model: a useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugs


orcid publication

SAR and 3D-QSAR studies on thiadiazolidinone derivatives: Exploration of structural requirements for glycogen synthase kinase 3 inhibitors


orcid publication

Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation


orcid publication

Molecular mechanics description of cytosine energy and geometry using preliminary ab initio results


orcid publication

Marine compounds for the therapeutic treatment of neurological disorders


orcid publication

Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques


orcid publication

Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: New disease-modifying agents for Alzheimer's disease


orcid publication

Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyryleholinesterase


orcid publication

Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors


orcid publication

Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE


orcid publication

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors


orcid publication

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease


orcid publication

Marine Compounds as a New Source for Glycogen Synthase Kinase 3 Inhibitors


orcid publication

Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases


orcid publication

Enantioselective LC/MS method for the determination of an antimalarial agent fenozan B07 in dog plasma


orcid publication

S4-04-06


orcid publication

NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: Potential therapeutic role in brain disorders


orcid publication

Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease


orcid publication

Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs


orcid publication

Potent beta-amyloid modulators


orcid publication

PDE7 inhibitors as new drugs for neurological and inflammatory disorders


orcid publication

Non-ATP competitive glycogen synthase kinase 3 beta (GSK-3 beta) inhibitors: Study of structural requirements for thiadiazolidinone derivatives


orcid publication

Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: Implication of ERK1/2 and PPAR gamma receptors


orcid publication

GSK-3 inhibitors: A ray of hope for the treatment of Alzheimer's disease?


orcid publication

CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example


orcid publication

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice


orcid publication

S4-02-03: TDZDS: Can we target tau, beta-amyloid and neurodegeneration simultaneously?


orcid publication

Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools


orcid publication

The first enantioselective synthesis of palinurin


orcid publication

Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties


orcid publication

Synthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 Inhibitors


orcid publication

NP04634 prevents cell damage caused by calcium overload and mitochondrial disruption in bovine chromaffin cells


orcid publication

Anticonvulsant and Neuroprotective Effects of the Novel Calcium Antagonist NP04634 on Kainic Acid-Induced Seizures in Rats


orcid publication

Advances in alzheimer therapy:Understanding Pharmacological approaches to the disease


orcid publication

Emerging Drugs and Targets for Alzheimer's Disease


orcid publication

Chapter 9. Tau Protein Kinases Inhibitors: From the Bench to the Clinical Trials


orcid publication

The potential role of glycogen synthase kinase 3 inhibitors as Amyotrophic lateral sclerosis pharmacological therapy


orcid publication

Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds


orcid publication

Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity


orcid publication

Protein Kinases CK1 and CK2 as New Targets for Neurodegenerative Diseases


orcid publication

Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease


orcid publication

PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury


orcid publication

Glycogen synthase kinase-3.


orcid publication

Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.


orcid publication

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.


orcid publication

Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities


orcid publication

An application of two MIFs-based tools (Volsurf plus and Pentacle) to binary QSAR: The case of a palinurin-related data set of non-ATP competitive Glycogen Synthase Kinase 3 beta (GSK-3 beta) inhibitors


orcid publication

The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury


orcid publication

Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model


orcid publication

Identification in Silico and Experimental Validation of Novel Phosphodiesterase 7 Inhibitors with Efficacy in Experimental Autoimmune Encephalomyelitis Mice


orcid publication

Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo


orcid publication

Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds


orcid publication

Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals


orcid publication

A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation


orcid publication

5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3 beta (GSK-3 beta) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood-brain barrier penetration and binding to human serum albumin


orcid publication

5-Imino-1,2,4-thiadiazoles: First small molecules As substrate competitive inhibitors of glycogen synthase kinase 3


orcid publication

beta-N-methylamino-L-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): The first step towards an experimental model for sporadic ALS


orcid publication

Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities


orcid publication

Regulation of Th1 Cells and Experimental Autoimmune Encephalomyelitis by Glycogen Synthase Kinase-3


orcid publication

Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease


orcid publication

Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease


orcid publication

Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival


orcid publication

Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.


orcid publication

Evidence for a new binding mode to GSK-3: Allosteric regulation by the marine compound palinurin


orcid publication

Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice


orcid publication

Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis


orcid publication

CHAPTER 12. Phosphodiesterase Inhibitors as a New Therapeutic Approach for the Treatment of Parkinson’s Disease


orcid publication

A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases


orcid publication

cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.


orcid publication

Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis


orcid publication

Phosphodiesterase 10 inhibitors: New disease modifying drugs for Parkinson's disease?


orcid publication

Modulation of cAMP-Specific PDE without Emetogenic Activity: New Sulfide-Like PDE7 Inhibitors


orcid publication

Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice


orcid publication

Crosstalk between Phosphodiesterase 7 and Glycogen Synthase Kinase-3: Two Relevant Therapeutic Targets for Neurological Disorders


orcid publication

CB1 Blockade Potentiates Down-Regulation of Lipogenic Gene Expression in Perirenal Adipose Tissue in High Carbohydrate Diet-Induced Obesity


Page 5 of 47
Go to Top